Literature DB >> 32163298

Factors associated with the activity and severity of bullous pemphigoid: a review.

Yangchun Liu1, Yiman Wang1, Xinyi Chen2, Hongzhong Jin1, Li Li1.   

Abstract

Bullous pemphigoid (BP) is the most common subepidermal autoimmune blistering disease. It usually affects people older than 70 years of age. The two main autoantigens are BP180 and BP230, both of which are components of hemidesmosomes. Immunoglobulin (Ig)G and IgE autoantibodies to BP180 detected by the enzyme-linked immunoassay (ELISA) show close associations with the activity and severity of BP. In addition, inflammatory cells (eosinophils, neutrophils and mast cells) and cytokines (e.g. interleukins and CC chemokine ligands) play an important part in the pathogenesis, activity and severity of BP. We summarized the potential contribution of each factor postulated to be associated with the activity and severity of BP, and provide guidance for clinicians to pay timely and close attention to such parameters. This review may also promote the development of novel therapies for BP.Key MessagesBullous Pemphigoid Disease Area Index (BPDAI) is a scoring system which can reflect the extent of clinical involvement of BP patients.The titres of IgE autoantibodies and IgG autoantibodies against the NC16A domain of BP180 are closely correlated with the activity and severity of BP.Many inflammatory cells and molecules, such as eosinophils and interleukins, can also reflect the activity and severity of BP.

Entities:  

Keywords:  BP180; BPDAI; antibody titre; inflammatory cells and molecules

Year:  2020        PMID: 32163298      PMCID: PMC7877946          DOI: 10.1080/07853890.2020.1742367

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  47 in total

1.  High levels of CCL26 in blister fluid and sera of patients with bullous pemphigoid.

Authors:  Shinji Kagami; Hiromichi Kai; Takashi Kakinuma; Tomomitsu Miyagaki; Masahiro Kamata; Makoto Sugaya; Kunihiko Tamaki; Shinichi Sato
Journal:  J Invest Dermatol       Date:  2011-09-01       Impact factor: 8.551

2.  Induced autoimmune bullous diseases.

Authors:  T Hashimoto
Journal:  Br J Dermatol       Date:  2017-02       Impact factor: 9.302

3.  Do reciprocal interactions between cell stress proteins and cytokines create a new intra-/extra-cellular signalling nexus?

Authors:  Brian Henderson; Frank Kaiser
Journal:  Cell Stress Chaperones       Date:  2013-07-25       Impact factor: 3.667

4.  Increased expression of NLRP3 inflammasome components and interleukin-18 in patients with bullous pemphigoid.

Authors:  Hui Fang; Shuai Shao; Tianyu Cao; Jie Lei; Erle Dang; Jieyu Zhang; Gang Wang
Journal:  J Dermatol Sci       Date:  2016-04-29       Impact factor: 4.563

Review 5.  Cytokines and bullous pemphigoid.

Authors:  L D'Auria; P Cordiali Fei; F Ameglio
Journal:  Eur Cytokine Netw       Date:  1999-06       Impact factor: 2.737

Review 6.  Heat shock protein 90: a pathophysiological factor and novel treatment target in autoimmune bullous skin diseases.

Authors:  Stefan Tukaj; Detlef Zillikens; Michael Kasperkiewicz
Journal:  Exp Dermatol       Date:  2015-06-03       Impact factor: 3.960

7.  Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity.

Authors:  F Ameglio; L D'Auria; C Bonifati; C Ferraro; A Mastroianni; B Giacalone
Journal:  Br J Dermatol       Date:  1998-04       Impact factor: 9.302

8.  Eosinophil Cationic Protein (ECP), a predictive marker of bullous pemphigoid severity and outcome.

Authors:  Delphine Giusti; Gregory Gatouillat; Sébastien Le Jan; Julie Plée; Philippe Bernard; Frank Antonicelli; Bach Nga Pham
Journal:  Sci Rep       Date:  2017-07-06       Impact factor: 4.379

9.  Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid.

Authors:  Sébastien Le Jan; Julie Plée; David Vallerand; Aurélie Dupont; Elodie Delanez; Anne Durlach; Patricia L Jackson; J Edwin Blalock; Philippe Bernard; Frank Antonicelli
Journal:  J Invest Dermatol       Date:  2014-07-19       Impact factor: 8.551

10.  IgG4 autoantibodies induce dermal-epidermal separation.

Authors:  Sidonia Mihai; Mircea T Chiriac; Josep E Herrero-González; Margaret Goodall; Roy Jefferis; Caroline O S Savage; Detlef Zillikens; Cassian Sitaru
Journal:  J Cell Mol Med       Date:  2007 Sep-Oct       Impact factor: 5.310

View more
  3 in total

Review 1.  A Review of the Immunologic Pathways Involved in Bullous Pemphigoid and Novel Therapeutic Targets.

Authors:  Mohsen Afarideh; Robert Borucki; Victoria P Werth
Journal:  J Clin Med       Date:  2022-05-18       Impact factor: 4.964

Review 2.  Dyshidrosiform Bullous Pemphigoid.

Authors:  Philip R Cohen
Journal:  Medicina (Kaunas)       Date:  2021-04-20       Impact factor: 2.430

3.  Rapid Disease Control in First-Line Therapy-Resistant Mucous Membrane Pemphigoid and Bullous Pemphigoid with Omalizumab as Add-On Therapy: A Case Series Of 13 Patients.

Authors:  Marina Alexandre; Gérôme Bohelay; Thomas Gille; Christelle Le Roux-Villet; Isaac Soued; Florence Morin; Frédéric Caux; Sabine Grootenboer-Mignot; Catherine Prost-Squarcioni
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.